验证数据展示
经过测试的应用
Positive IF/ICC detected in | LPS and Brefeldin A treated RAW 264.7 cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:125-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
82706-6-RR targets FGF-21 in IF/ICC, ELISA applications and shows reactivity with Mouse samples.
经测试应用 | IF/ICC, ELISA Application Description |
经测试反应性 | Mouse |
免疫原 | Fusion Protein 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Recombinant |
产品类型 | Antibody |
全称 | fibroblast growth factor 21 |
别名 | Fgf21, fibroblast growth factor 21 |
计算分子量 | 23kd |
GenBank蛋白编号 | NM_020013 |
基因名称 | FGF-21 |
Gene ID (NCBI) | 56636 |
RRID | AB_3670534 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Protein A purification |
UNIPROT ID | Q9JJN1 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Fibroblast growth factor 21 (FGF21), a member of the FGF superfamily, has emerged as an important metabolic regulator. FGF21 is produced in the liver, adipocytes and skeletal muscle and regulates glucose, energy and lipid metabolism. FGF21 is a stress-responsive hepatokine which is induced in the liver as a response to injury, regeneration, hepatocarcinogenesis and during kidney dysfunction. FGF21 is primarily metabolized in the kidney and renal secretion is the major route of FGF21 elimination. Its plasma levels increase according to the decline in renal function in patients with chronic and acute renal dysfunction.
实验方案
Product Specific Protocols | |
---|---|
IF protocol for FGF-21 antibody 82706-6-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |